Exelixis Non Current Liabilities Other from 2010 to 2024
| EXEL Stock | USD 23.70 0.17 0.72% |
Non Current Liabilities Other | First Reported 2011-03-31 | Previous Quarter 61.6 M | Current Value 94.2 M | Quarterly Volatility 64 M |
Check Exelixis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Exelixis main balance sheet or income statement drivers, such as Interest Expense of 64.9 M, Total Revenue of 1.9 B or Gross Profit of 1.8 B, as well as many exotic indicators such as Price To Sales Ratio of 3.81, Dividend Yield of 0.0 or PTB Ratio of 4.24. Exelixis financial statements analysis is a perfect complement when working with Exelixis Valuation or Volatility modules.
Exelixis | Non Current Liabilities Other |
Latest Exelixis' Non Current Liabilities Other Growth Pattern
Below is the plot of the Non Current Liabilities Other of Exelixis over the last few years. It is Exelixis' Non Current Liabilities Other historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Exelixis' overall financial position and show how it may be relating to other accounts over time.
| Non Current Liabilities Other | 10 Years Trend |
|
Non Current Liabilities Other |
| Timeline |
Exelixis Non Current Liabilities Other Regression Statistics
| Arithmetic Mean | 44,610,480 | |
| Geometric Mean | 16,248,155 | |
| Coefficient Of Variation | 150.95 | |
| Mean Deviation | 45,243,440 | |
| Median | 17,339,000 | |
| Standard Deviation | 67,339,819 | |
| Sample Variance | 4534.7T | |
| Range | 258.2M | |
| R-Value | 0.58 | |
| Mean Square Error | 3241.1T | |
| R-Squared | 0.34 | |
| Significance | 0.02 | |
| Slope | 8,732,351 | |
| Total Sum of Squares | 63485.1T |
Exelixis Non Current Liabilities Other History
About Exelixis Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Exelixis income statement, its balance sheet, and the statement of cash flows. Exelixis investors use historical funamental indicators, such as Exelixis's Non Current Liabilities Other, to determine how well the company is positioned to perform in the future. Although Exelixis investors may use each financial statement separately, they are all related. The changes in Exelixis's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Exelixis's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Exelixis Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Exelixis. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Non Current Liabilities Other | 94.2 M | 98.9 M |
Pair Trading with Exelixis
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Exelixis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will appreciate offsetting losses from the drop in the long position's value.Moving against Exelixis Stock
| 0.68 | ETON | Eton Pharmaceuticals Upward Rally | PairCorr |
| 0.62 | SBFMW | Sunshine Biopharma | PairCorr |
| 0.61 | EVOK | Evoke Pharma | PairCorr |
| 0.48 | DVAX | Dynavax Technologies Financial Report 7th of May 2024 | PairCorr |
| 0.43 | EGRX | Eagle Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to Exelixis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Exelixis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Exelixis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Exelixis to buy it.
The correlation of Exelixis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Exelixis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Exelixis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Exelixis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Exelixis Correlation against competitors. For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.Note that the Exelixis information on this page should be used as a complementary analysis to other Exelixis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for Exelixis Stock analysis
When running Exelixis' price analysis, check to measure Exelixis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Exelixis is operating at the current time. Most of Exelixis' value examination focuses on studying past and present price action to predict the probability of Exelixis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Exelixis' price. Additionally, you may evaluate how the addition of Exelixis to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Exelixis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.99) | Earnings Share 0.65 | Revenue Per Share 5.753 | Quarterly Revenue Growth 0.131 | Return On Assets 0.0355 |
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.